Literature DB >> 33445091

Emotion regulation and borderline personality features in daily life: The role of social context.

Katherine L Dixon-Gordon1, Skye Fitzpatrick2, Lauren A Haliczer3.   

Abstract

BACKGROUND: Borderline personality disorder (BPD) is associated with emotional dysfunction and interpersonal sensitivity. Yet, little work has characterized how BPD features predicts emotional reactivity and emotion regulation behaviors in response to interpersonal stress relative to other forms of stress.
METHODS: Participants were 152 university students who completed baseline measures of BPD features and complied with two-week daily diary procedures assessing daily emotion regulation strategy use in response to social and non-social stressors.
RESULTS: Generalized estimating equations revealed that BPD features predicted greater negative and positive emotions in response to daily stressors, and interacted with type of stressor in predicting urges and behaviors. Elevated BPD features was associated with greater urges for dysfunctional emotion regulatory behaviors and fewer functional emotion regulatory behaviors to a greater extent in response to social (versus non-social) stressors. LIMITATIONS: This study was limited by its focus on past-day retrospective recall. Further, the student sample limits the generalizability of these findings.
CONCLUSIONS: These findings suggest that individuals with elevated BPD features may have less functional emotion regulation in social contexts.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Borderline personality disorder (BPD); Emotion dysregulation; Emotion regulation

Mesh:

Year:  2020        PMID: 33445091     DOI: 10.1016/j.jad.2020.12.125

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  1 in total

1.  Perceived emotion invalidation predicts daily affect and stressors.

Authors:  Melissa J Zielinski; Jennifer C Veilleux; Marley F Fradley; Kayla D Skinner
Journal:  Anxiety Stress Coping       Date:  2022-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.